Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
29.08.2023 22:05:00

Aflac Incorporated to Present at the 2023 KBW Insurance Conference

COLUMBUS, Ga., Aug. 29, 2023 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that Vice President of Investor and Rating Agency Relations David A. Young will participate in a fireside chat at the 2023 KBW Insurance Conference on September 7, 2023 at 3:05 p.m. ET.

The presentation will be webcast live at the following link:

https://wsw.com/webcast/kbw102/afl/1563285

Please plan to register for the webcast at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation will be available within 24 hours after conclusion of the live event for one year using the same web address.

ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than 67 years to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance policies in force. In 2021, the company became a signatory of the Principles for Responsible Investment (PRI). In 2022, the company was included in the Dow Jones Sustainability North America Index for the ninth year, the World's Most Ethical Companies by Ethisphere for the 17th consecutive year, Fortune's World's Most Admired Companies for the 22nd time and Bloomberg's Gender-Equality Index for the fourth consecutive year. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/espanol. Investors may learn more about Aflac Incorporated and its commitment to ESG and social responsibility at investors.aflac.com under "Sustainability."

1 LIMRA 2021 U.S. Supplemental Health Insurance Total Market Report

FORWARD-LOOKING INFORMATION
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. The company desires to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as "expect," "anticipate," "believe," "goal," "objective," "may," "should," "estimate," "intends," "projects," "will," "assumes," "potential," "target," "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.

The company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:

  • difficult conditions in global capital markets and the economy, including those caused by COVID-19
  • defaults and credit downgrades of investments
  • global fluctuations in interest rates and exposure to significant interest rate risk
  • concentration of business in Japan
  • limited availability of acceptable yen-denominated investments
  • foreign currency fluctuations in the yen/dollar exchange rate
  • differing interpretations applied to investment valuations
  • significant valuation judgments in determination of expected credit losses recorded on the Company's investments
  • decreases in the Company's financial strength or debt ratings
  • decline in creditworthiness of other financial institutions
  • concentration of the Company's investments in any particular single-issuer or sector
  • major public health issues, the effects of COVID-19 and its variants (both known and emerging), and any resulting economic effects and government interventions, on the Company's business and financial results
  • the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners
  • deviations in actual experience from pricing and reserving assumptions
  • ability to continue to develop and implement improvements in information technology systems
  • interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems
  • subsidiaries' ability to pay dividends to the Parent Company
  • inherent limitations to risk management policies and procedures
  • operational risks of third party vendors
  • tax rates applicable to the Company may change
  • failure to comply with restrictions on policyholder privacy and information security
  • extensive regulation and changes in law or regulation by governmental authorities
  • competitive environment and ability to anticipate and respond to market trends
  • catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics (such as COVID-19), tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, terrorism or other acts of violence, and damage incidental to such events
  • ability to protect the Aflac brand and the Company's reputation
  • ability to effectively manage key executive succession
  • changes in accounting standards
  • level and outcome of litigation
  • allegations or determinations of worker misclassification in the United States

 

(PRNewsfoto/Aflac Incorporated)

Analyst and investor contact – David A. Young, 706.596.3264 or 800.235.2667 or dyoung@aflac.com

Media contact – Ines Gutzmer, 762.207.7601 or igutzmer@aflac.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aflac-incorporated-to-present-at-the-2023-kbw-insurance-conference-301912950.html

SOURCE Aflac Incorporated

Analysen zu Aflac Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Aflac Inc 107,90 0,89% Aflac Inc